Akums Drugs & Pharmaceuticals Board of Directors

Get the latest insights into the leadership at Akums Drugs & Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Sanjeev Jain Managing Director
Mr. Sandeep Jain Managing Director
Mr. Sanjay Sinha Whole Time Director
Mr. Sunil Kumar Thakur Non Executive Director
Ms. Matangi Gowrishankar Independent Director
Mr. Kewal Kundanlal Handa Independent Director
Mr. Satwinder Singh Independent Director

Akums Drugs & Pharmaceuticals Share price

AKUMS

463.4

4.50 (-0.96%)
NSE
BSE
Last updated on 29 Aug, 2025 | 12:01 IST
BUYSELL
Today's High

469.55

Today's Low

460.00

52 Week Low

405.00

52 Week High

968.90

The current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals FAQs

The board at Akums Drugs & Pharmaceuticals consists of experienced professionals, including Mr. Sanjeev Jain , Mr. Sandeep Jain , and others, overseeing the company’s strategic and corporate governance.

Directors at Akums Drugs & Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Sanjeev Jain is the current chairman at Akums Drugs & Pharmaceuticals.

Executive directors at Akums Drugs & Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Akums Drugs & Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Akums Drugs & Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.